Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
description Rank Gene Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2580 to 2629 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to expressed sequence aa415817. [source:sptrembl;acc:q8n4q9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
631\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.141\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05993\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to expressed sequence ai415388 (fragment). [source:sptrembl;acc:q8n428]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1813\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.854\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01168\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to glucosamine-phosphate n-acetyltransferase (hypothetical protein flj33258). [source:sptrembl;acc:q96ek6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.288\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00102\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to kinase suppressor of ras (fragment). [source:sptrembl;acc:q8ivt5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2071\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.555\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.807\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0081\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to lim domain only 7 (fragment). [source:sptrembl;acc:q8n6m2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1750\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01264\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to lysozyme c-1 (1,4-beta-n-acylmuramidase c, ec 3.2.1.17). [source:refseq;acc:nm\_032517]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3032\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
similar to mob-lak. [source:refseq;acc:nm\_145279]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2937\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to nuclear protein e3-3 orf1. [source:sptrembl;acc:q9bu61]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
803\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to putative transmembrane protein; homolog of yeast golgi membrane protein yif1p (yip1p-interacting factor). [source:refseq;acc:nm\_033557]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1957\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.633\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.703\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1090\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
226.218\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02945\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to trna synthetase class ii. [source:refseq;acc:nm\_152268]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2714\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.224\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.348\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00056\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
similar to zinc finger protein 277. [source:sptrembl;acc:q8wwa6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1086\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
236.679\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.679\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02958\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sin3 associated polypeptide p18 (2hor0202). [source:swissprot;acc:o00422]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1454\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.024\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.089\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01964\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sin3 associated polypeptide p30; sin3-associated polypeptide, 30kd. [source:refseq;acc:nm\_003864]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2207\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
199.129\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00645\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
675\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
226.497\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.355\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05664\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sipl protein. [source:refseq;acc:nm\_018269]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2247\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00609\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sirtuin 1; sir2-like 1; sirtuin type 1; sir2alpha; sirtuin silent mating type information regulation 2 homolog 1 (s. cerevisiae). [source:refseq;acc:nm\_012238]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2731\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.922\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.985\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0003\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sirtuin 7; sir2-related protein type 7; sirtuin type 7; sirtuin (silent mating type information regulation 2, s.cerevisiae, homolog) 7; silent mating type information regulation 2, s.cerevisiae, homolog 7; sirtuin silent mating type information regulation 2 homolog 7 (s. cerevisiae). [source:refseq;acc:nm\_016538]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
935\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
232.473\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.372\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
skd1 protein (vacuolar sorting protein 4b). [source:swissprot;acc:o75351]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3037\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
skeletal muscle and kidney enriched inositol phosphatase isoform 1; 43-kda form skeletal muscle and kidney enriched inositol phosphatase. [source:refseq;acc:nm\_016532]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2994\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
skeletal muscle lim-protein 2 (slim 2) (four and a half lim domains protein 3) (fhl-3). [source:swissprot;acc:q13643]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1198\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
276.454\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02546\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
skeletal muscle lim-protein 3 (slim 3) (lim-domain protein dral) (four and a half lim domains protein 2) (fhl-2). [source:swissprot;acc:q14192]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1195\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
269.608\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
276.493\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02554\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
skeletal muscle tropomodulin (sk-tmod) (tropomodulin 4). [source:swissprot;acc:q9nzq9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2332\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.258\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.294\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00452\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small edrk-rich factor 2. [source:refseq;acc:nm\_005770]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2947\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2637\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.075\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00126\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small glutamine-rich tetratricopeptide repeat-containing protein (vpu-binding protein) (ubp). [source:swissprot;acc:o43765]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2748\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
189.563\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
189.531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00017\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small gtp-binding tumor suppressor 1. [source:refseq;acc:nm\_145173]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
891\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.028\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.055\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03907\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein associated protein n (snrnp-n) (sm protein n) (sm-n) (smn) (sm-d) (tissue-specific splicing protein). [source:swissprot;acc:p14648]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3004\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein associated proteins b and b' (snrnp-b) (sm protein b/b') (sm-b/sm-b') (smb/smb'). [source:swissprot;acc:p14678]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3012\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein e (snrnp-e) (sm protein e) (sm-e) (sme). [source:swissprot;acc:p08578]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
388\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
227.575\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
208.756\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09015\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein f (snrnp-f) (sm protein f) (sm-f) (smf). [source:swissprot;acc:q15356]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
389\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d1 (snrnp core protein d1) (sm-d1) (sm-d autoantigen). [source:swissprot;acc:p13641]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
173\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.032\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.056\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17599\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d2 (snrnp core protein d2) (sm-d2). [source:swissprot;acc:p43330]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
225\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
226.471\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.769\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12243\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d3 (snrnp core protein d3) (sm-d3). [source:swissprot;acc:p43331]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
245\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
226.109\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.333\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11751\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small optic lobes homolog; small optic lobes, drosophila, homolog of. [source:refseq;acc:nm\_005632]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1346\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.772\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.594\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02224\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
smooth muscle cell lim protein (cysteine-rich protein 2) (crp2) (lim-only protein 5). [source:swissprot;acc:q16527]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
232\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
239.336\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.879\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
snare associated protein snapin. [source:refseq;acc:nm\_012437]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1163\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.758\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.097\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02632\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
snrna activating protein complex 50 kda subunit (snapc 50 kda subunit) (proximal sequence element-binding transcription factor beta subunit) (pse-binding factor beta subunit) (ptf beta subunit). [source:swissprot;acc:q92966]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2849\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sodium-dependent multivitamin transporter (na(+)-dependent multivitamin transporter). [source:swissprot;acc:q9y289]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2000\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.626\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.739\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00931\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sodium/iodide cotransporter (na(+)/i(-) cotransporter) (sodium-iodide symporter) (na+/i-symporter). [source:swissprot;acc:q92911]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1996\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.682\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.784\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00936\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-1 chain precursor (ec 3.6.3.9) (sodium pump 1) (na+/k+ atpase 1). [source:swissprot;acc:p05023]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1424\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
214.717\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.157\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02068\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-2 chain precursor (ec 3.6.3.9) (sodium pump 2) (na+/k+ atpase 2). [source:swissprot;acc:p50993]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1428\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-3 chain (ec 3.6.3.9) (sodium pump 3) (na+/k+ atpase 3) (alpha(iii)). [source:swissprot;acc:p13637]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1427\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
soluble liver antigen/liver pancreas antigen. [source:refseq;acc:nm\_153825]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1911\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01033\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2456\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
204.683\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
205.326\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00314\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2458\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2455\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2454\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [source:swissprot;acc:q9ugq3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2047\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
224.124\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.003\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00838\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [source:swissprot;acc:q9ny64]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2048\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/